Aurobindo Pharma Limited
2,574words
0turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
(E), MUMBAI -400 051 To The Corporate Relations Department BSE LIMITED Phiroz Jeejeebhoy Towers, 25th floor, Dalal Street, MUMBAI -400 001 Company Code No. AUROPHARMA Company Code No. 524804
15.5%
Rs Crore) Net Debt to Equity 965 837 954 1,002 1,403 1,151 -0.06 -0.06 -0.04 -0.05 15.5% 14.6% 14.9% 15.5% 16.8% 19.4% Q1FY23 Q2FY23 Q3FY23 Q4FY23 Q1FY24 Q2FY24 % Margin -0.11
14.6%
e) Net Debt to Equity 965 837 954 1,002 1,403 1,151 -0.06 -0.06 -0.04 -0.05 15.5% 14.6% 14.9% 15.5% 16.8% 19.4% Q1FY23 Q2FY23 Q3FY23 Q4FY23 Q1FY24 Q2FY24 % Margin -0.11 Q1FY23
14.9%
Debt to Equity 965 837 954 1,002 1,403 1,151 -0.06 -0.06 -0.04 -0.05 15.5% 14.6% 14.9% 15.5% 16.8% 19.4% Q1FY23 Q2FY23 Q3FY23 Q4FY23 Q1FY24 Q2FY24 % Margin -0.11 Q1FY23 -0.11
16.8%
y 965 837 954 1,002 1,403 1,151 -0.06 -0.06 -0.04 -0.05 15.5% 14.6% 14.9% 15.5% 16.8% 19.4% Q1FY23 Q2FY23 Q3FY23 Q4FY23 Q1FY24 Q2FY24 % Margin -0.11 Q1FY23 -0.11 Q2FY23 Q3FY2
19.4%
837 954 1,002 1,403 1,151 -0.06 -0.06 -0.04 -0.05 15.5% 14.6% 14.9% 15.5% 16.8% 19.4% Q1FY23 Q2FY23 Q3FY23 Q4FY23 Q1FY24 Q2FY24 % Margin -0.11 Q1FY23 -0.11 Q2FY23 Q3FY23 Q4FY
24
%
-0.04 -0.05 15.5% 14.6% 14.9% 15.5% 16.8% 19.4% Q1FY23 Q2FY23 Q3FY23 Q4FY23 Q1FY24 Q2FY24 % Margin -0.11 Q1FY23 -0.11 Q2FY23 Q3FY23 Q4FY23 Q1FY24 Q2FY24 5 Consolidated Financial & Bus
Rs 7,219 crore
FY24 Q2FY24 5 Consolidated Financial & Business Highlights – Q2 FY24 Revenue from operations at Rs 7,219 crore, an increase of 25.8% YoY | US revenues (excl. Puerto Rico) at US$ 409 Mn EBITDA before Forex and
25.8%
inancial & Business Highlights – Q2 FY24 Revenue from operations at Rs 7,219 crore, an increase of 25.8% YoY | US revenues (excl. Puerto Rico) at US$ 409 Mn EBITDA before Forex and Other income at Rs 1,4
Rs 1,403 crore
25.8% YoY | US revenues (excl. Puerto Rico) at US$ 409 Mn EBITDA before Forex and Other income at Rs 1,403 crore | EBITDA margin is at 19.4% Net Profit after minority interest is at Rs 752 crore (YoY growth: 84
Rs 752 crore
her income at Rs 1,403 crore | EBITDA margin is at 19.4% Net Profit after minority interest is at Rs 752 crore (YoY growth: 84% & QoQ growth: 32%) | Net profit margin is at 10.4% Basic & Diluted EPS is Rs 12.8
84%
re | EBITDA margin is at 19.4% Net Profit after minority interest is at Rs 752 crore (YoY growth: 84% & QoQ growth: 32%) | Net profit margin is at 10.4% Basic & Diluted EPS is Rs 12.83 | YoY growth of
Advertisement